CINRYZE

CINRYZE® is an injectable prescription medicine indicated for use in children (6 years old and above), teenagers and adults with HAE. Do not use if you have had hypersensitivity reactions to CINRYZE. See important safety information and patient labeling... CINRYZE has been available since 2008 for adolescents and adults. More than 1,000 physicians have prescribed CINRYZE to more than 2,000 patients, resulting in over 709,000 distributed doses... CINRYZE addresses the deficiency or dysfunction of C1-INH. CINRYZE can reduce vascular permeability by preventing the generation of bradykinin. 1,3

Primary location: Lexington United States